NOVARTIS AG;GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED;NOVARTIS PHARMA AG
发明人:
申请号：
IL23515914
公开号：
IL235159D0
申请日:
2014.10.19
申请国别(地区):
IL
年份:
2014
代理人:
摘要：
Invented is a method of treating steroid responsive dermatoses in a mammal, including a human, in need thereof which comprises the administration of a therapeutically effective amount of a compound selected from the group consisting of: N-{(1S)-2-Amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide or a pharmaceutically acceptable salt thereof, and the compound N-{(1S)-2-amino-1-[(3,4-difluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-furancarboxamide or a pharmaceutically acceptable salt thereof, to such mammal.
